News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-15 pm EDT			5-day change	1st Jan Change
65.35 ^USD	-8.40%		-8.38%	-11.67%

02:17pm	Exact Sciences Names Aaron Bloomer CFO	MT
Apr. 11	Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exact Sciences Names Aaron Bloomer CFO	08:17am	MT
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer	06:03am	BU
Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes	Apr. 11	MT
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes	Apr. 11	BU
Exact Sciences Corporation announced that it expects to receive $266.8 million in funding	Apr. 09	CI
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024	Apr. 08	BU
Exact Sciences Schedules First Quarter 2024 Earnings Call	Apr. 08	BU
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment	Apr. 04	BU
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer	Apr. 01	AQ
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	Mar. 28	BU
Exact Sciences Corp. Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	Mar. 28	CI
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner	Mar. 27	BU
Transcript : Exact Sciences Corporation - Special Call	Mar. 14
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study	Mar. 13	BU
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer	Mar. 07	BU
Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing	Mar. 05	MT
Transcript : Exact Sciences Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 01:30 PM	Mar. 04
EXACT SCIENCES LAUNCHES RISKGUARD HEREDITARY CANCER TEST IN THE UNITED STATES	Feb. 29	AQ
Exact Sciences Insider Sold Shares Worth $356,302, According to a Recent SEC Filing	Feb. 29	MT
Exact Sciences to Participate in March Investor Conference	Feb. 26	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Summary

Filters